177 related articles for article (PubMed ID: 28266596)
1. Bioinformatics analysis of the proteins interacting with LASP-1 and their association with HBV-related hepatocellular carcinoma.
Kong FY; Zhu T; Li N; Cai YF; Zhou K; Wei X; Kou YB; You HJ; Zheng KY; Tang RX
Sci Rep; 2017 Mar; 7():44017. PubMed ID: 28266596
[TBL] [Abstract][Full Text] [Related]
2. HBX protein promotes LASP-1 expression through activation of c-Jun in human hepatoma cells.
You H; Kong F; Zhou K; Wei X; Hu L; Hu W; Luo W; Kou Y; Liu X; Chen X; Zheng K; Tang R
J Cell Physiol; 2018 Sep; 233(9):7279-7291. PubMed ID: 29600594
[TBL] [Abstract][Full Text] [Related]
3. LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.
Wang H; Li W; Jin X; Cui S; Zhao L
Eur J Cancer; 2013 Mar; 49(4):974-83. PubMed ID: 23084841
[TBL] [Abstract][Full Text] [Related]
4. Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells.
Salvi A; Bongarzone I; Miccichè F; Arici B; Barlati S; De Petro G
Neoplasia; 2009 Feb; 11(2):207-19. PubMed ID: 19177205
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of LASP-1 expression reveals vimentin as its new partner in human hepatocellular carcinoma cells.
Salvi A; Bongarzone I; Ferrari L; Abeni E; Arici B; De Bortoli M; Scuri S; Bonini D; Grossi I; Benetti A; Baiocchi G; Portolani N; De Petro G
Int J Oncol; 2015 May; 46(5):1901-12. PubMed ID: 25760690
[TBL] [Abstract][Full Text] [Related]
6. LASP-1 induces proliferation, metastasis and cell cycle arrest at the G2/M phase in gallbladder cancer by down-regulating S100P via the PI3K/AKT pathway.
Li Z; Chen Y; Wang X; Zhang H; Zhang Y; Gao Y; Weng M; Wang L; Liang H; Li M; Zhang F; Zhao S; Liu S; Cao Y; Shu Y; Bao R; Zhou J; Liu X; Yan Y; Zhen L; Dong Q; Liu Y
Cancer Lett; 2016 Mar; 372(2):239-50. PubMed ID: 26797416
[TBL] [Abstract][Full Text] [Related]
7. LIM and SH3 protein-1 modulates CXCR2-mediated cell migration.
Raman D; Sai J; Neel NF; Chew CS; Richmond A
PLoS One; 2010 Apr; 5(4):e10050. PubMed ID: 20419088
[TBL] [Abstract][Full Text] [Related]
8. Nuclear import of LASP-1 is regulated by phosphorylation and dynamic protein-protein interactions.
Mihlan S; Reiß C; Thalheimer P; Herterich S; Gaetzner S; Kremerskothen J; Pavenstädt HJ; Lewandrowski U; Sickmann A; Butt E
Oncogene; 2013 Apr; 32(16):2107-13. PubMed ID: 22665060
[TBL] [Abstract][Full Text] [Related]
9. Suppression of LASP-1 attenuates the carcinogenesis of prostatic cancer cell lines: Key role of the NF-κB pathway.
Sun W; Guo L; Shao G; Liu X; Guan Y; Su L; Zhao S
Oncol Rep; 2017 Jan; 37(1):341-347. PubMed ID: 27840958
[TBL] [Abstract][Full Text] [Related]
10. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
[TBL] [Abstract][Full Text] [Related]
11. The cytoskeletal protein LASP-1 differentially regulates migratory activities of choriocarcinoma cells.
Segerer SE; Bartmann C; Kaspar S; Müller N; Kapp M; Butt E; Kämmerer U
Arch Gynecol Obstet; 2016 Feb; 293(2):407-14. PubMed ID: 26232936
[TBL] [Abstract][Full Text] [Related]
12. LASP-1, a novel urinary marker for detection of bladder cancer.
Ardelt P; Grünemay N; Strehl A; Jilg C; Miernik A; Kneitz B; Butt E
Urol Oncol; 2013 Nov; 31(8):1591-8. PubMed ID: 22481019
[TBL] [Abstract][Full Text] [Related]
13. LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex.
Duvall-Noelle N; Karwandyar A; Richmond A; Raman D
Oncogene; 2016 Mar; 35(9):1122-33. PubMed ID: 25982273
[TBL] [Abstract][Full Text] [Related]
14. Silencing of LIM and SH3 Protein 1 (LASP-1) Inhibits Thyroid Cancer Cell Proliferation and Invasion.
Gao W; Han J
Oncol Res; 2017 Jul; 25(6):879-886. PubMed ID: 27938497
[TBL] [Abstract][Full Text] [Related]
15. LASP-1 interacts with ErbB2 in ovarian cancer cells.
Sidhanth C; Bindhya S; Shabna A; Krishnapriya S; Manasa P; Nagare RP; Joshua T; Sneha S; Murhekar K; Ganesan TS
Biochem J; 2022 Jan; 479(1):23-38. PubMed ID: 34881777
[TBL] [Abstract][Full Text] [Related]
16. Screening and bioinformatics analysis of circular RNA expression profiles in hepatitis B-related hepatocellular carcinoma.
Wang S; Cui S; Zhao W; Qian Z; Liu H; Chen Y; Lv F; Ding HG
Cancer Biomark; 2018; 22(4):631-640. PubMed ID: 29914004
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of LIM and SH3 Protein 1 leading to accelerated G2/M phase transition contributes to enhanced tumourigenesis in oral cancer.
Shimizu F; Shiiba M; Ogawara K; Kimura R; Minakawa Y; Baba T; Yokota S; Nakashima D; Higo M; Kasamatsu A; Sakamoto Y; Tanzawa H; Uzawa K
PLoS One; 2013; 8(12):e83187. PubMed ID: 24386158
[TBL] [Abstract][Full Text] [Related]
18. Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer.
Frietsch JJ; Grunewald TG; Jasper S; Kammerer U; Herterich S; Kapp M; Honig A; Butt E
Br J Cancer; 2010 May; 102(11):1645-53. PubMed ID: 20461080
[TBL] [Abstract][Full Text] [Related]
19. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
20. Investigating lasp-2 in cell adhesion: new binding partners and roles in motility.
Bliss KT; Chu M; Jones-Weinert CM; Gregorio CC
Mol Biol Cell; 2013 Apr; 24(7):995-1006. PubMed ID: 23389630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
